Guidance| Page 2 of 4 | The British Society of Gastroenterology

Guidance

Caution about the use of ulipristal acetate (Esmya)

First published on 05 Apr 2018

Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]

Guidance

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

First published on 21 Feb 2018

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Guidance

BSG guidance on vaccination against MAP in humans

First published on 21 Nov 2017

Dr AB Hawthorne, Chair BSG IBD Section, October 2016 (planned review date: October 2017) A vaccine has been developed that could be used in patients with Crohn’s disease, and phase 1 trials are planned to start at the end of […]

Guidance

Endoscopy Global Rating Scale

First published on 21 Nov 2017

Accreditation assessments for services in England, Wales, Northern Ireland and Scotland, including the independent sector are now conducted via https://www.thejag.org.uk

Guidance

Guidance for Endoscopic Ultrasonography – UK EUS Users’ Groups

First published on 21 Nov 2017

Guidance

BSG guidance on the use of faecal calprotectin testing in IBD

First published on 21 Nov 2017

Updated guidance document on use of faecal calprotectin – both in assessment of GI symptoms, and also in patients with known IBD. Dr Barney Hawthorne, Chair BSG IBD Section Committee, October 2016. Differentiation between inflammatory bowel disease (IBD) and functional […]

Guidance

Guidance on Decontamination of Equipment for Gastrointestinal Endoscopy: 2017 Edition

First published on 16 Nov 2017

The Report of a Working Party of the British Society of Gastroenterology Endoscopy Committee April 2017 Flexible endoscopes are complex reusable instruments that require unique consideration with respect to decontamination. Their external surfaces and internal channels for air, water, aspiration […]

Guidance

BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy

First published on 04 Apr 2017

The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]

Guidance

NICE guidance on molecular testing strategies for Lynch syndrome in people with colorectal cancer

First published on 01 Feb 2017

An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]

Guidance

Rapid Colorectal Diagnostic Pathway

First published on 04 Oct 2016

Following extensive discussion and a multi-stakeholder workshop with NHS England in late 2016 a set of principles has been agreed for a Rapid Colorectal Diagnostic Pathway following the introduction of a non-mandated Best Practice Tariff in England. The BSG recommends […]